Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Oncology Institute (TOI) Asset Utilization Ratio (2021 - 2025)

Oncology Institute's Asset Utilization Ratio history spans 5 years, with the latest figure at 3.06 for Q4 2025.

  • For Q4 2025, Asset Utilization Ratio rose 36.98% year-over-year to 3.06; the TTM value through Dec 2025 reached 3.06, up 36.98%, while the annual FY2025 figure was 2.98, 44.67% up from the prior year.
  • Asset Utilization Ratio reached 3.06 in Q4 2025 per TOI's latest filing, up from 2.85 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 3.06 in Q4 2025 to a low of 0.33 in Q1 2021.
  • Average Asset Utilization Ratio over 5 years is 1.52, with a median of 1.32 recorded in 2023.
  • The largest YoY upside for Asset Utilization Ratio was 212.26% in 2022 against a maximum downside of 1.1% in 2022.
  • A 5-year view of Asset Utilization Ratio shows it stood at 0.94 in 2021, then decreased by 1.1% to 0.93 in 2022, then skyrocketed by 63.82% to 1.52 in 2023, then soared by 47.43% to 2.24 in 2024, then surged by 36.98% to 3.06 in 2025.
  • Per Business Quant, the three most recent readings for TOI's Asset Utilization Ratio are 3.06 (Q4 2025), 2.85 (Q3 2025), and 2.62 (Q2 2025).